Ergebnis der Suchanfrage nach D&amp

FAMAR Group

FAMAR Group: Dr. Riku Rautsola Appointed New CEO

Athens, Greece (ots/PRNewswire) - After 16 years with FAMAR, including the last 4 years as CEO, Konstantinos Rengis decided to step down from his role for personal reasons, effective September 29, 2025. Kostas is widely recognized for his customer-centric approach, deep knowledge of our industry, and his solution-oriented mindset. During his tenure, he played a pivotal role in successfully guiding the company through ...

Europäischer Rechnungshof - European Court of Auditors

Research and development: Unclear if EU regional specialisation lives up to lofty promises

Hellmann Worldwide Logistics

3

Hellmann partners with Siemens Smart Infrastructure for global central warehouse in Nuremberg

Reach MENA

TruReach China Launches at DMEXCO: Direct Marketing Gateway in Europe to Affluent Chinese Travelers via Alibaba’s Fliggy / European brands gain new access to China’s $250 billion outbound tourism market with verified travel intent data and

Cologne (ots) - Reach MENA (www.reachmena.com), an end-to-end marketing agency targeting affluent Chinese travellers, today announced the European launch of its new brand, TruReach China, the exclusive agent of Alibaba’s Fliggy in Germany as the first move of the expansion in Europe markets. While Chinese ...

GEA Group Aktiengesellschaft

3

GEA unveils a new generation of flexible, modular beverage filling technology at drinktec 2025

REMA TIP TOP AG

REMA TIP TOP Acquires Key Assets of Almex Group, Strengthening Global Position in Conveyor Technology

AVATR

AVATR VISION XPECTRA Made Its Global Debut, and Several Star Models Unveil at the Munich Auto Show (IAA) / Emotive Luxury, Born Global: New Luxury AVATR Goes Global

Fraunhofer Institut für Angewandte Festkörperphysik IAF

Semiconductor technology for broadband satellite communications achieves record efficiency

hubergroup Deutschland GmbH

3

Press Release - hubergroup at IndiaCorr Expo: HYDRO-i returns to where it all began

Servier

Servier acquires potential treatment for Fragile X syndrome, the most common genetic cause of autism spectrum disorder

Suresnes, France (ots/PRNewswire) - - Servier acquires KER-0193, a potential treatment for Fragile X syndrome, developed by Kaerus Bioscience, a Medicxi company - KER-0193, a novel, orally bioavailable small molecule, was granted Orphan Drug Designation and Rare Pediatric Drug Designation by U.S. FDA - Acquisition ...

nova-Institut GmbH

5

CO₂-based Fuels and Chemicals Conference 2026 – Call for Abstracts Now Open

UCB

UCB presents latest research and clinical advancement across leading epilepsy portfolio at International Epilepsy Congress

Brussels (ots/PRNewswire) - - 26 scientific abstracts, including two oral presentations, demonstrate UCB's ongoing commitment to advancing research for people living with epilepsies - Data include an open-label extension study describing the long-term safety of FINTEPLA®▼ (fenfluramine)[1] and global functioning ...

nova-Institut GmbH

3

Advanced Recycling Conference 2025: From Industry Crossroads to Circularity

Ottobock SE & Co. KGaA

Ottobock with strong H1 2025 results

Infineon Technologies AG

Infineon strengthens startup ecosystem in India

cooldown°earth foundation

cooldown°earth welcomes North Rhine-Westphalia (NRW) funding for matterr / – Public funds and public welfare capital accelerate circular technology -

Helmholtz Munich

2

New Endoscopy Technology Enables Early Detection of Esophageal Cancer

Drees & Sommer SE

Drees & Sommer Designs Advanced Semiconductor R&D Facility for imec in Málaga

Technische Universität München

A new biotech hub for Munich

TECHNICAL UNIVERSITY OF MUNICH NEWS RELEASE A new biotech hub for Munich Where science powers start-ups: Launching BioLabs|TUM • TUM Venture Labs cooperate with BioLabs and Lilly • 1,800 square meters of coworking lab space • Aiming at accelerating therapy development BioLabs, TUM Venture Labs, and Eli Lilly and Company (Lilly) today launched BioLabs|TUM, a new biotechnology innovation hub in central Munich. The initiative aims to empower early-stage biotech start-ups ...

Yanfeng

Yanfeng Unveils 2024 ESG Report: Driving Sustainability Forward

Helmholtz Munich

Therapeutic Vaccine for Chronic Hepatitis B Enters First Clinical Trial in Patients

PNO Innovation GmbH

TherVacB: Advance Curative Strategy for Chronic Hepatitis B

Helmholtz Munich

Cancer Cachexia: Liver Identified as Driver of Body Wasting

Many people with cancer experience dramatic loss of muscle and fat tissue. In many cases, even the heart muscle is affected, which further weakens the body. This wasting syndrome, known as cachexia, affects around half of all cancer patients. It is a major cause of therapy resistance, complications, and increased mortality. ...

Debtist GmbH

Debtist opens office in United Kingdom: Digital debt collection now also in the British market